8.49 -0.06 (-0.70%)
After hours: 5:09PM EST
|Bid||8.49 x 1100|
|Ask||8.56 x 1200|
|Day's Range||8.46 - 8.76|
|52 Week Range||6.47 - 14.50|
|Beta (3Y Monthly)||2.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 26, 2020 - Mar 2, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.58|
AlgoSec, the leading provider of business-driven network security management solutions, today announced the appointment of two key executives to its global management team as the company focuses on driving revenue and multi-faceted business growth into the new decade. Chris Thomas joins AlgoSec in the role of Chief Revenue Officer with 25 years’ experience in enterprise and channel technology sales and partnerships. Most recently, Mr. Thomas held the position of SVP, Worldwide Sales for Vidyo, an enterprise-grade unified communications platform for businesses and developers.
ROCK HILL, S.C., Nov. 19, 2019 /PRNewswire/ -- At Formnext 2019, 3D Systems (DDD) is showcasing its new, application-specific production solutions for the Healthcare, Aerospace, and Automotive industries. The company has the unique ability to architect solutions specific to customers' needs through a combination of its breakthrough materials, hardware platforms, software, and professional services - creating a path forward to integrating additive into traditional production environments.
- VisiJet® M2S-HT90 possesses best-in-class high heat deflection temperature (HDT) and meets USP Class VI standards for biocompatibility making it ideal for Automotive, Consumer Goods and Healthcare applications ...
- HARTING Applied Technologies and VMR GmbH & Co. KG rely on 3D Systems' Cimatron integrated CAD/CAM software to enhance data integration through the entire mold-making process, improve tools quality, ...
We'd be surprised if 3D Systems Corporation (NYSE:DDD) shareholders haven't noticed that the Co-Founder, Charles Hull...
ROCK HILL, S.C., Nov. 6, 2019 /PRNewswire/ -- Today, 3D Systems (DDD) announced that its new biocompatible denture material, NextDent® Denture 3D+, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The combination of this new dental 3D printing material, NextDent 5100 dental 3D printer, and industry-leading intra-oral scanning and dental software solutions yields an end-to-end digital dentistry solution.
Macroeconomic headwinds, bleak automotive sector and irregular ordering patterns of key customers hurt 3D Systems' (DDD) third-quarter results. However, cost-controlling efforts are a positive.
3D Systems (DDD) delivered earnings and revenue surprises of 0.00% and 2.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ROCK HILL, S.C., Oct. 30, 2019 -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the third quarter ended September 30, 2019. For the third.
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing […]
ROCK HILL, S.C., Oct. 28, 2019 /PRNewswire/ -- 3D Systems (DDD) today announced it has been awarded a contract to conduct research and development of a Corrosion Performance Design Guide for Direct Metal Printing of Nickel Alloys. 3D Systems received the award based on its ability to thoroughly collect corrosion data and apply its expertise on the effects of various production practices associated with parts built via direct metal printing (DMP). The company's particular technology is ideal for shipbuilding and munition fabrication due to its low oxygen content and superior part quality control.
3D Systems (DDD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ROCK HILL, S.C. and LEUVEN, Belgium, Oct. 23, 2019 /PRNewswire/ -- Today, 3D Systems (DDD) and Antleron are announcing a collaboration, intended to play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry. Bringing together two industry pioneers – 3D Systems for 3D printing technologies and healthcare expertise, and Antleron for leadership and innovation in the development of regenerative products and personalized patient care - the companies will collaborate to support Antleron's development of bioprinting solutions utilizing 3D Systems' printing technologies.
Stratasys' (SSYS) new 3D printer is especially beneficial for medical device companies, which require new ways to drive faster adoption of technologies and procedures.
ROCK HILL, S.C., Oct. 02, 2019 -- 3D Systems (NYSE:DDD) announced today it plans to hold a conference call and simultaneous webcast to discuss its financial results for the.
ROCK HILL, S.C., Sept. 30, 2019 /PRNewswire/ -- Today, 3D Systems (DDD) announced that three leading mold-making shops - Allegiance Mold, Liberty Molds, Inc., and Synergy MouldWorks, Inc.—have addressed market demand for more complex and successful injection mold tooling through the deployment of 3D Systems' Cimatron® integrated CAD/CAM software. Cimatron software is drawing renewed interest from customers building complex tools as it enables them to move straight from design to the shop floor, ultimately allowing for improved mold design time and time to delivery by up to 50% and 20% respectively.
- 3D Systems' VSP technology and anatomic model services have supported more than 120,000 unique patient cases. - 3D Systems draws upon its experience and expertise in virtual surgical planning to develop a new, personalized approach to Orthopaedic surgery. ROCK HILL, S.C., Sept. 26, 2019 /PRNewswire/ -- 3D Systems (DDD) announced that the Food and Drug Administration (FDA) has provided 510(k) clearance to its new VSP Orthopaedics solution -- enabling surgeons to obtain a clear 3D visualization of a patient's anatomy and develop a personalized surgical plan, prior to entering the operating room. The expansion of 3D Systems' VSP service-based approach into the field of orthopaedic surgery builds on its VSP technology and anatomic modeling leadership – having helped with more than 120,000 unique patient cases in its 25 years of experience.
ROCK HILL, S.C., Sept. 24, 2019 /PRNewswire/ -- Today, 3D Systems (DDD) unveiled Figure 4 Production Black 10 (PRO-BLK 10) - a revolutionary production material for additive manufacturing applications that enables manufacturers to directly produce end-use plastic parts without tooling. Figure 4 PRO-BLK 10 is 3D Systems' first photopolymer for additive manufacturing that exhibits thermoplastic behaviors, providing a combination of speed, accuracy, strength and durability previously only associated with injection molding output. The breakthrough material works with a simple isopropyl alcohol (IPA) wash and does not require a secondary thermal post-cure process, which significantly improves throughput yield and significantly reduces the extensive solvent cleaning cycles needed with other technologies.
Anyone researching 3D Systems Corporation (NYSE:DDD) might want to consider the historical volatility of the share...
ROCK HILL, S.C., Sept. 18, 2019 /PRNewswire/ -- Lonati, a world leader in the production of machines for the hosiery industry, has selected 3D Systems' (DDD) additive manufacturing solutions to redefine its production workflow.
3D Systems' (DDD) D2P's automatic segmentation tools enable medical practitioners to create accurate, digital 3D anatomic models from medical imaging data.
ROCK HILL, S.C., Sept. 12, 2019 /PRNewswire/ -- 3D Systems (DDD) announced today it received additional 510(k) clearance for its D2P™ (DICOM-to-PRINT) software allowing clinicians to 3D print diagnostic patient-specific anatomic models. 3D Systems is the only company to offer a solution that combines its own software and printers to create 3D printed patient-specific anatomic models for diagnostic purposes in an unmatched breadth of medical specialties including: cardiovascular, craniofacial, gastrointestinal, genitourinary, neurological, and musculoskeletal applications.